ALC News and Press, Alcon Inc. From 09/04/22

Summary Alcon has continued in a downtrend since September 2021 with persistent mean reversion activity across this time. With FY22 guidance narrowed and macro-headwinds prevailing, forward-looking multiples are less attractive to peers. We see a value gap to the downside in A...

Alcon (NYSE: ALC) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has announced entry into a definitive merger agreement where Alcon will acquire Aerie.  Alcon will add commercial products Rocklatan and Rhopressa and a pipeline of several clinical and preclinical o...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock.com Aerie Pharmaceuticals (NASDAQ: AERI ) stock is rising higher on Tuesday following news of an acquisition deal with Alcon (NYSE: ALC ). Alcon is agreeing to acquire Aerie Pharma...

BTIG says that the decision by Swiss eye care company Alcon ( NYSE: ALC ) to acquire U.S.-based Aerie Pharmaceuticals, Inc. ( AERI ) “makes a lot of sense” as the former seeks to expand in glaucoma, a common eye condition that can lead to vision loss. ALC i...

Builds on Alcon’s existing commercial expertise in the estimated $20 billion global ophthalmic pharmaceutical segment 1 Adds Rocklatan ® and Rhopressa ® , and a pipeline of several clinical and preclinical ophthalmic pharmaceutical produc...

Kahn Brothers' 13F portfolio value decreased from ~$788M to ~$743M this quarter. New York Community Bancorp, Citigroup, VOXX International, and ViewRay were increased while decreasing Patterson-UTI Energy during the quarter. The portfolio continues to be very concentrated with the...

Societe Generale has downgraded Alcon ( NYSE: ALC ) to hold from buy as the eye care company's immunity to macro headwinds is declining. The firm has a price target of CHF73.6 (~9% upside based on Thursday's close on the SIX Swiss Exchange). Analyst Delphine Le Louet s...

Alcon Inc. (ALC) Q2 2022 Results Conference Call August 10, 2022 08:00 AM ET Company Participants Dan Cravens - VP and Global Head IR David Endicott - CEO Tim Stonesifer - CFO Conference Call Participants Zach Weiner - Jeffries Chris Cooley - Step...

Alcon press release ( NYSE: ALC ): Q2 Non-GAAP EPS of $0.63 beats by $0.07 . Revenue of $2.2B (+5.3% Y/Y) in-line. FY22 Guidance: Net Sales of $8.6B-$8.8B from prior outlook of $8.7 to $8.9 billion vs. consensus of $8.84B Core EPS of $2.20-$2.30 from prior ...

Strong second quarter sales of $2.2 billion, up 5%, or 10% constant currency (cc) Second quarter earnings of $0.30 per diluted share, down 3%, or up 34% cc Second quarter core earnings of $0.63 per diluted share, up 13%, or 30% cc Updated 2022 full year outlo...